{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:31:47Z","timestamp":1787344307543,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23EY036499"],"award-info":[{"award-number":["K23EY036499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007337","name":"Massachusetts Eye and Ear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018133","name":"VitreoRetinal Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ophtha.2024.12.037","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T19:18:11Z","timestamp":1736018291000},"page":"654-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cost-effectiveness Analysis of Digital Therapeutics for Amblyopia"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0676-0752","authenticated-orcid":false,"given":"Irene","family":"Koc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-5811","authenticated-orcid":false,"given":"Saghar","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-9629","authenticated-orcid":false,"given":"Rachel K.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1855-1459","authenticated-orcid":false,"given":"Nour Abou","family":"Shousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnoush","family":"Mahmoudinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isdin","family":"Oke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-4794","authenticated-orcid":false,"given":"David G.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-6104","authenticated-orcid":false,"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2024.12.037_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ophtha.2011.06.024","article-title":"Amblyopia prevalence and risk factors in Australian preschool children","volume":"119","author":"Pai","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bjo.2007.134700","article-title":"Prevalence and risk factors for common vision problems in children: data from the ALSPAC study","volume":"92","author":"Williams","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ophtha.2007.08.001","article-title":"Prevalence of amblyopia and strabismus in African American and Hispanic Children ages 6 to 72 months: the Multi-ethnic Pediatric Eye Disease Study","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib4","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/S0140-6736(14)60522-5","article-title":"Whole-population vision screening in children aged 4\u20135 years to detect amblyopia","volume":"385","author":"Solebo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2024.12.037_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cxo.12663","article-title":"The functional impact of amblyopia","volume":"101","author":"Webber","year":"2018","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ophtha.2024.12.037_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/eye.2011.4","article-title":"Amblyopia and quality of life: a systematic review","volume":"25","author":"Carlton","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2024.12.037_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2022.11.003","article-title":"Amblyopia Preferred Practice Pattern","volume":"130","author":"Cruz","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.visres.2015.02.012","article-title":"Compliance and patching and atropine amblyopia treatments","volume":"114","author":"Wang","year":"2015","journal-title":"Vision Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj\/eye\/6700086","article-title":"Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children","volume":"16","author":"Searle","year":"2002","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2024.12.037_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1076\/stra.10.2.79.8143","article-title":"A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia","volume":"10","author":"Loudon","year":"2002","journal-title":"Strabismus"},{"key":"10.1016\/j.ophtha.2024.12.037_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jaapos.2010.07.009","article-title":"Evaluating the burden of amblyopia treatment from the parent and child\u2019s perspective","volume":"14","author":"Felius","year":"2010","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2024.12.037_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1091-8531(04)00161-2","article-title":"Risk of amblyopia recurrence after cessation of treatment","volume":"8","author":"Holmes","year":"2004","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2024.12.037_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.visres.2015.02.009","article-title":"Amblyopia and the binocular approach to its therapy","volume":"114","author":"Hess","year":"2015","journal-title":"Vision Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2012.11.001","article-title":"Amblyopia and binocular vision","volume":"33","author":"Birch","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib15","doi-asserted-by":"crossref","first-page":"160.e1","DOI":"10.1016\/j.jaapos.2019.02.007","article-title":"Binocular amblyopia treatment with contrast-rebalanced movies","volume":"23","author":"Birch","year":"2019","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2024.12.037_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jaapos.2015.08.003","article-title":"Dichoptic movie viewing treats childhood amblyopia","volume":"19","author":"Li","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2024.12.037_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ophtha.2021.09.001","article-title":"Randomized controlled trial of a dichoptic digital therapeutic for amblyopia","volume":"129","author":"Xiao","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ophtha.2022.10.020","article-title":"An eye-tracking\u2013based dichoptic home treatment for amblyopia: a multicenter randomized clinical trial","volume":"130","author":"Wygnanski-Jaffe","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-814276-9.00018-0","article-title":"Pharmacoeconomic analyses and modeling","author":"Thomas","year":"2019","journal-title":"Clinical Pharmacy Education, Practice and Research: Clinical Pharmacy, Drug Information, Pharmacovigilance"},{"key":"10.1016\/j.ophtha.2024.12.037_bib20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","article-title":"Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states","volume":"110","author":"Brown","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib21","first-page":"14","article-title":"Evidence-based medicine and cost-effectiveness","volume":"26","author":"Brown","year":"1999","journal-title":"J Health Care Finance"},{"key":"10.1016\/j.ophtha.2024.12.037_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0039-6257(02)00457-5","article-title":"Health care economic analyses and value-based medicine","volume":"48","author":"Brown","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib23","first-page":"473","article-title":"Vision and quality-of-life","volume":"97","author":"Brown","year":"1999","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.ophtha.2024.12.037_bib24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.oret.2024.05.011","article-title":"A cost effectiveness analysis of avacincaptad pegol for the treatment of geographic atrophy with comparison to pegcetacoplan","volume":"8","author":"Patel","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.oret.2023.08.003","article-title":"A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy","volume":"8","author":"Patel","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.oret.2021.08.004","article-title":"Cost-utility analysis of mycophenolate mofetil versus methotrexate for noninfectious uveitis","volume":"5","author":"Al-khersan","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.oret.2021.09.005","article-title":"A cost-effectiveness analysis of intravitreal aflibercept for the prevention of progressive diabetic retinopathy","volume":"6","author":"Patel","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.oret.2022.11.010","article-title":"Aflibercept monotherapy versus bevacizumab-first for diabetic macular edema: a cost analysis based on Diabetic Retinopathy Clinical Research Network protocol AC results","volume":"7","author":"Patel","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.oret.2022.05.021","article-title":"Cost analysis: port delivery system versus monthly ranibizumab for wet age-related macular degeneration treatment","volume":"6","author":"Al-khersan","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2024.12.037_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ajo.2020.05.029","article-title":"Cost-utility analysis of VEGF inhibitors for treating neovascular age-related macular degeneration","volume":"218","author":"Brown","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/opep.9.1.1.1715","article-title":"Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusion","volume":"9","author":"Brown","year":"2002","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0161-6420(00)00169-X","article-title":"Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization","volume":"107","author":"Brown","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00055735-200006000-00004","article-title":"The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis","volume":"11","author":"Sharma","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.12.037_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.104.4.e47","article-title":"Cost-effectiveness of treatment for threshold retinopathy of prematurity","volume":"104","author":"Brown","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2024.12.037_bib35","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0161-6420(02)01286-1","article-title":"A cost-utility analysis of therapy for amblyopia","volume":"109","author":"Membreno","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.2003.028712","article-title":"Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model","volume":"88","author":"K\u00f6nig","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.120.3.268","article-title":"A randomized trial of atropine vs patching for treatment of moderate amblyopia in children","volume":"120","author":"Glaser","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2017.12.033","article-title":"Vision-related quality of life associated with unilateral and bilateral ocular conditions","volume":"125","author":"Brown","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.12.037_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11584630-000000000-00000","article-title":"Sensitivity analysis in cost-effectiveness studies: from guidelines to practice","volume":"29","author":"Jain","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ophtha.2024.12.037_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00019053-200017050-00006","article-title":"Handling uncertainty in cost-effectiveness models","volume":"17","author":"Briggs","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ophtha.2024.12.037_bib42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2024.12.037_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/bmj.39301.460150.55","article-title":"Objectively monitored patching regimens for treatment of amblyopia: randomised trial","volume":"335","author":"Stewart","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2024.12.037_bib45","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1167\/iovs.04-0250","article-title":"Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS)","volume":"45","author":"Stewart","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2024.12.037_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaapos.2012.10.021","article-title":"The effect of amblyopia treatment on stereoacuity","volume":"17","author":"Stewart","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2024.12.037_bib47","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bjo.2008.149815","article-title":"Psychological causes of non-compliance with electronically monitored occlusion therapy for amblyopia","volume":"93","author":"Loudon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.12.037_bib48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/adc.2005.090373","article-title":"Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study","volume":"91","author":"Dixon-Woods","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ophtha.2024.12.037_bib49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3928\/01913913-20141021-08","article-title":"Use of atropine penalization to treat amblyopia in UK orthoptic practice","volume":"51","author":"Piano","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.ophtha.2024.12.037_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.visres.2015.01.002","article-title":"Stereopsis and amblyopia: a mini-review","volume":"114","author":"Levi","year":"2015","journal-title":"Vision Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.visres.2010.09.029","article-title":"Visual deficits in anisometropia","volume":"51","author":"Levi","year":"2011","journal-title":"Vision Res"},{"key":"10.1016\/j.ophtha.2024.12.037_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1167\/3.5.5","article-title":"The pattern of visual deficits in amblyopia","volume":"3","author":"McKee","year":"2003","journal-title":"J Vis"},{"key":"10.1016\/j.ophtha.2024.12.037_bib53","doi-asserted-by":"crossref","first-page":"P105","DOI":"10.1016\/j.ophtha.2017.10.008","article-title":"Amblyopia Preferred Practice Pattern\u00ae","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024008017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024008017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:29:04Z","timestamp":1774344544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642024008017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0161642024008017"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.12.037","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness Analysis of Digital Therapeutics for Amblyopia","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}